TEMIT HY22 swings to NZ$191.9m loss as portfolio revaluation reverses

What changed

Revenue, which for this investment trust is essentially portfolio dividend income, fell 6.3% to NZ$32.3m from NZ$34.5m. The far larger move was below that line: profit before tax swung NZ$708.0m to a loss of NZ$185.2m from a profit of NZ$522.9m, and net profit after tax swung to a loss of NZ$191.9m from NZ$543.6m. Operating cash inflow halved to NZ$23.4m from NZ$47.6m. Cash on the balance sheet fell to NZ$40.7m from NZ$97.8m, while gross borrowings edged up to NZ$100.5m, lifting net debt to NZ$59.7m from NZ$2.2m. Equity still rose 5.6% to NZ$2.4b, consistent with the headline loss reflecting fair-value revaluation rather than capital impairment.

What matters

• The PBT and NPAT swing is a portfolio valuation effect, not operating decay. Revenue only fell 6.3%, yet PBT moved by NZ$708.0m. The effective tax rate was broadly stable (3.6% vs 4.0%), so the cleaner operating read is that dividend income held up reasonably while unrealised gains of the prior year reversed into losses this period. ROE consequently flipped to -8.1% from +24.3%.
• The cash position materially weakened. Operating cash conversion deteriorated (OCF down 50.9% on a 6.3% income decline), investing turned into a NZ$33.1m outflow from a prior inflow, and financing absorbed NZ$34.7m. Net cash fell NZ$44.5m, and net debt rose to NZ$59.7m.
• Dividend signalling is partial. The release references an interim and a special dividend, but per-share figures and payout ratios are not provided in the extraction, so capital-return sustainability cannot be tested against the reduced income base.

Expectations

No formal target or guidance was disclosed. Management explicitly stated it is "too early to predict revenues for the full year" and reiterated that earnings are typically first-half weighted. On the prior-year shape, HY21 accounted for 57.6% of FY21 revenue and 796.9% of FY21 NPAT, the latter reflecting that the second half of FY21 itself swung to an implied NZ$475.4m NPAT loss. Annualising HY22 revenue gives NZ$64.7m, about 7.9% above FY21's NZ$59.9m, but given the acknowledged first-half skew that annualisation should not be read as a run-rate. The release supports a view that dividend income is tracking broadly in line; it does not support any view on portfolio-valuation direction for the second half.

Quality of result

The 6.3% dividend-income decline is the durable, operating component of the result and is modest. The NZ$735.5m NPAT swing is valuation-driven and, by construction for an investment trust, will be volatile and non-recurring in character. Operating cash of NZ$23.4m is meaningfully below the NZ$32.3m income line, and receivable days lengthened to 44.2 from 39.9, flagging weaker cash conversion that warrants attention even if small in absolute terms. The balance sheet has also been assisted less than it appears: equity growth reflects prior-period retained value, while the liquidity buffer has compressed sharply.

Unresolved

• What portion of the NZ$708.0m PBT swing is realised losses versus unrealised mark-to-market, and how is that split disclosed in the fuller financial report?
• What were the full per-share interim and special dividend declarations for HY22 versus HY21, and what is the implied payout against the lower income base?
• Why did operating cash fall 50.9% when dividend income fell only 6.3%? Is this timing on withholding tax refunds (prior-year excerpts reference a "tax repayment") or a genuine collection lag?
• What drove the NZ$33.1m swing in investing cash flow, and is the drawn NZ$100.5m borrowing intended to remain outstanding given the smaller cash buffer?

This briefing cannot assess the portfolio's underlying holdings, NAV per share, or benchmark-relative performance, none of which are quantified in the supplied extraction.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.